Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

CB-154

Known as: CB 154, CB154 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1982
Highly Cited
1982
The effects of bromocryptine (CB-154) on prolactin (PRL) and luteinizing hormone (LH) secretion were studied in lactating sows… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
1981
Highly Cited
1981
PRL involvement in periparturient mammary development and onset of milk secretion was studied in 17 multiparous, monotocous… 
Highly Cited
1981
Highly Cited
1981
The influence of periparturient secretion of PRL on cytological differentiation of mammary epithelial cells was studied in 17… 
Highly Cited
1980
Highly Cited
1980
Twenty-four women with regular cycles who reported moderate to severe premenstrual tension participated in a double-blind study… 
1979
1979
lypophysectomized adult male rats with a pituitary transplant under the kidney capsule were used to study the effects of chronic… 
1977
1977
Thirty acromegalic subjects underwent chronic CB154 therapy (10-20 mg daily) for periods ranging from 3 months up to 2 years. In… 
Highly Cited
1976
Highly Cited
1976
Plasma testosterone, androstenedione, oestradiol-17beta, follicle stimulating hormone (FSH) and luteinizing hormone (LH) were not… 
Highly Cited
1974
Highly Cited
1974
ABSTRACT A single oral dose of 2–Br–α–ergocryptine (CB154) lowers considerably plasma GH levels in 7 acromegalic patients. The… 
Highly Cited
1974
Highly Cited
1974
ABSTRACT Nine female patients with galactorrhea were selected for treatment with Bromocriptin® (CB-154), a specific inhibitor of… 
Highly Cited
1972
Highly Cited
1972
ABSTRACT A single dose of 2 Bro-α-ergocryptine (CB-154) lowers serum prolactin for at least 12 hrs. in normal subjects. CB-154 in…